Cefdinir Dosage Calculator

Cefdinir Dosage Calculator: Formula, Variables, and Clinical Guidance

Cefdinir is a third-generation oral cephalosporin antibiotic used to treat mild-to-moderate bacterial infections including community-acquired pneumonia (CAP), acute maxillary sinusitis, acute exacerbations of chronic bronchitis, pharyngitis and tonsillitis caused by Streptococcus pyogenes, acute bacterial otitis media, and uncomplicated skin and skin-structure infections. Accurate dosing — especially in pediatric patients — is critical for achieving therapeutic plasma concentrations while avoiding toxicity and antimicrobial resistance. The cefdinir dosage calculator applies the weight-based formula from the FDA-approved prescribing information to compute the correct milligram dose for each patient automatically.

The Dosing Formula

The calculator uses the following formula:

Dose (mg) = min(Weight (kg) × Rate (mg/kg), Maximum Dose)

This expression multiplies the patient's body weight in kilograms by the weight-based dosing rate in mg/kg, then caps the result at the established maximum dose ceiling. For pediatric patients aged 6 months to 12 years, weight-based dosing ensures proportional systemic drug exposure matched to body size. The maximum dose cap prevents supratherapeutic exposure in heavier children whose computed dose would otherwise exceed safe limits. For adolescents and adults (age 13 and older), the dose is fixed regardless of body weight, consistent with the FDA label for cefdinir capsules and oral suspension published on DailyMed (Cefdinir for Oral Suspension USP).

Variables Explained

• Patient Weight (kg): The patient's body weight in kilograms. This variable is used exclusively for pediatric weight-based dosing (6 months to 12 years). Adolescent and adult dosing is fixed; weight does not factor into those calculations.
• Age Group: Determines which dosing strategy applies. Pediatric patients (6 months to 12 years) receive weight-based doses. Adolescents and adults (13 years and older) receive fixed standard doses per the prescribing schedule.
• Dosing Frequency:
  • q12h (every 12 hours): Pediatric rate of 7 mg/kg per dose, with a maximum of 300 mg per dose. Fixed adult and adolescent dose is 300 mg every 12 hours.
  • q24h (every 24 hours): Pediatric rate of 14 mg/kg per dose, with a maximum of 600 mg per day. Fixed adult and adolescent dose is 600 mg once daily. Note: once-daily dosing is not recommended for skin and skin-structure infections or community-acquired pneumonia, per FDA labeling.

Worked Example: Pediatric Patient

Consider a child aged 5 years weighing 20 kg, prescribed cefdinir q12h for acute bacterial otitis media. Applying the formula: 20 kg × 7 mg/kg = 140 mg per dose. Since 140 mg falls below the 300 mg maximum, the full computed dose is prescribed — 140 mg every 12 hours for 10 days. If that same child weighed 50 kg (an unusually heavy child still under 13), the formula yields 50 × 7 = 350 mg, which exceeds the 300 mg cap. The dose is therefore limited to the maximum of 300 mg every 12 hours.

Worked Example: Adult Patient

An adult patient aged 35 weighing 80 kg with acute maxillary sinusitis receives a fixed cefdinir dose of 300 mg every 12 hours for 10 days, or alternatively 600 mg once daily — provided the indication is not a skin infection or CAP. Body weight is not a factor in adult dosing calculations, as confirmed by the Mayo Clinic Antimicrobial Therapy Guide (MC2499).

Dose Rounding in Pediatric Practice

After computing the weight-based dose, clinicians typically round to the nearest commercially available suspension volume. Cefdinir oral suspension is commonly formulated at 125 mg/5 mL and 250 mg/5 mL concentrations. Rounding to the nearest 0.5 mL or 1 mL facilitates accurate measurement by caregivers at home. Research from the PMC study on Automated Dose-Rounding Recommendations for Pediatric Medications supports structured rounding protocols to minimize administration errors with oral liquid antibiotics in the outpatient setting.

Clinical Limitations and Safety Considerations

This calculator provides a reference dose based on published FDA labeling. The following factors require individualized clinical assessment and are not incorporated into the formula:

• Renal impairment: Creatinine clearance below 30 mL/min requires dose reduction to 300 mg once daily (adults) or 7 mg/kg once daily up to 300 mg/day (pediatric).
• Drug interactions: Antacids containing aluminum or magnesium and iron supplements can reduce cefdinir absorption by up to 80%; administer these agents at least 2 hours apart from cefdinir.
• Allergy history: Do not use cefdinir in patients with known hypersensitivity to cephalosporins; cross-reactivity with penicillins is possible.
• Age restriction: Cefdinir is not approved for infants under 6 months of age.

Always verify the computed dose against current prescribing information and consult a licensed pharmacist or physician before administering any antibiotic.